You are here: Industry Insights > funding

News List

Pfizer to redistribute research funding biospectrumasia
January 09, 2018
Pfizer is expected to eliminate 300 positions from the neuroscience discovery and early development programs.
MicuRx Announces Closing of ¥100 Million Funding prnasia
December 08, 2017
MicuRx Pharmaceuticals, Inc. today announced closing of ¥100 million private financing led by Chinese affiliates of the existing MicuRx investors Delian Capital and BVCF
ADC Bio to Bioconjugation facility receives $11 million investment pharmaasia
September 28, 2017
Customer demand for ‘Lock-Release’ aggregation control technology a key driver behind the ADC Bio expansion into clinical and commercial drug manufacturing.
WuXi raises Series B funding biospectrumasia
September 22, 2017
The investment will accelerate the growth of WuXi NextCODE’s platform infrastructure and bring new users onboard through precision medicine and diagnostics partnerships.
Swedish startup raises €5.1 million funding biospectrumasia
September 07, 2017
Aifloo is described as an e-health system designed to improve the quality of life for the elderly and provide peace of mind for relatives and caregivers.
Vaccine market expected to grow at a CAGR of 7.5% by 2022 pharmaasia
August 29, 2017
The vaccine market is forecast to reach US$49.27 billion by 2022 at a CAGR of 7.5% from US$34.30 billion in 2017.
Japan’s Z- Works raises funding biospectrumasia
July 03, 2017
Z-Works has developed an IoT-based platform called Life Engine, aiming to reduce the burden of professionals and family members caring for elderly people.
Zai Lab raises $30 Million funding biospectrumasia
June 30, 2017
The new financing round has attracted support from both new and existing investors including blue chip US healthcare public investment funds.
China’s iCarbonX invests in funding HealthLoop biospectrumasia
June 29, 2017
iCarbonX plans to integrate HealthLoop’s patients-generated data to advance its data mining technology and help establish its digital life ecosystem.
University of Maryland team lands $6M in NIH funding for novel HCV vaccine fiercepharma
June 14, 2017
Next-gen hepatitis C drugs, notably Gilead’s Sovaldi and Harvoni, have cured many patients in the last few years, but we’re still short of a prophylactic vaccine.

Previous page 1 2 3 4 5 6 Next page